- Research article
- Open Access
A short upstream promoter region mediates transcriptional regulation of the mouse doublecortin gene in differentiating neurons
BMC Neuroscience volume 11, Article number: 64 (2010)
Doublecortin (Dcx), a MAP (Microtubule-Associated Protein), is transiently expressed in migrating and differentiating neurons and thereby characterizes neuronal precursors and neurogenesis in developing and adult neurogenesis. In addition, reduced Dcx expression during development has been related to appearance of brain pathologies. Here, we attempt to unveil the molecular mechanisms controlling Dcx gene expression by studying its transcriptional regulation during neuronal differentiation.
To determine and analyze important regulatory sequences of the Dcx promoter, we studied a putative regulatory region upstream from the mouse Dcx coding region (pdcx 2kb) and several deletions thereof. These different fragments were used in vitro and in vivo to drive reporter gene expression. We demonstrated, using transient expression experiments, that pdcx 2kb is sufficient to control specific reporter gene expression in cerebellar cells and in the developing brain (E14.5). We determined the temporal profile of Dcx promoter activity during neuronal differentiation of mouse embryonic stem cells (mESC) and found that transcriptional activation of the Dcx gene varies along with neuronal differentiation of mESC. Deletion experiments and sequence comparison of Dcx promoters across rodents, human and chicken revealed the importance of a highly conserved sequence in the proximal region of the promoter required for specific and strong expression in neuronal precursors and young neuronal cells. Further analyses revealed the presence in this short sequence of several conserved, putative transcription factor binding sites: LEF/TCF (Lymphoid Enhancer Factor/T-Cell Factor) which are effectors of the canonical Wnt pathway; HNF6/OC2 (Hepatocyte Nuclear Factor-6/Oncecut-2) members of the ONECUT family and NF-Y/CAAT (Nuclear Factor-Y).
Studies of Dcx gene regulatory sequences using native, deleted and mutated constructs suggest that fragments located upstream of the Dcx coding sequence are sufficient to induce specific Dcx expression in vitro: in heterogeneous differentiated neurons from mESC, in primary mouse cerebellar neurons (PND3) and in organotypic slice cultures. Furthermore, a region in the 3'-end region of the Dcx promoter is highly conserved across several species and exerts positive control on Dcx transcriptional activation. Together, these results indicate that the proximal 3'-end region of the mouse Dcx regulatory sequence is essential for Dcx gene expression during differentiation of neuronal precursors.
The DCX gene is located on the X chromosome (Xq22.3-q23) and encodes a 40 kDa phosphoprotein of 360 amino acids. The DCX protein is a microtubule-associated protein (MAP) that interacts with and stabilizes the microtubule cytoskeleton [1, 2]. This gene is specifically and transiently expressed in proliferating neuronal progenitors and in post-mitotic neuronal precursors during embryonic development and in neurogenic regions of the adult brain [2–5]. DCX expression occurs during corticogenesis and is absent during regenerative axonal growth, suggesting that DCX is a selective marker of cells committed to the neuronal lineage in both developing and adult brain [6, 7]. One or more mutations in the DCX gene cause X-Linked Subcortical Laminar Band Heterotopia (X-SCLH)/Lissencephaly (LIS) [2, 8]. This developmental brain malformation syndrome is caused by abnormal neuronal migration leading to a profound cerebral cortical layer disorganization resulting in mental retardation and epilepsy.
Such alterations in cortical lamination observed in humans were not detected in mice with Dcx gene deletion; lamination defects were only observed in the hippocampus . In contrast, RNA interference (RNAi)-mediated knock-down of Dcx in rodents caused impairment in radial migration of cortical neurons [10, 11]. Similarly, mice with mutations of both Dcx and Dclk (Doublecortin-like kinase gene, homolog of the Dcx gene) genes presented both disorganized neocortical lamination and severe cytoarchitectural defects of the hippocampus, suggesting redundant functions of Dcx and Dclk during neuronal migration [12–14].
Neuronal differentiation is a tightly orchestrated time- and location-dependent process in which many extracellular and intrinsic factors are involved [15–17]. Whereas the temporal and spatial Dcx expression patterns and Dcx post-translational regulations are well known, Dcx transcriptional regulation is poorly understood. However, to understand the mechanisms involved in neuronal differentiation during embryogenesis and more precisely in stages before neuronal determination, it is crucial to investigate the transcriptional gene control in action during neuronal differentiation. In view of the relevance of Dcx as a marker for neurogenesis and considering the importance of understanding Dcx gene regulation, we analyzed a putative regulatory region upstream of the mouse Dcx gene (pdcx 2kb) and used it to drive reporter gene expression. We characterized the Dcx promoter activity at different time-points during neuronal differentiation of mESC (mouse embryonic stem cells) and we defined a small region as an element required to provide specific and strong expression in neuronal precursors and young neuronal cells.
To study transcriptional regulation of the mouse doublecortin gene (Accession number NT_039718), we selected a 2kb-long fragment upstream of the transcription initiation site of the longest reported Dcx mRNA transcript (Accession number NM_001110222). This 2kb-long fragment (pdcx 2kb) contained TATA and CAAT boxes and was cloned into promoterless reporter (eGFP or Luciferase) vectors for analysis (Figure 1a).
Cell type-specific activity of the 2kb-long Dcx promoter fragment
We first wanted to determine whether pdcx 2kb was sufficient to induce transcriptional activity and to drive it specifically in cells expressing the endogenous Dcx gene, namely neuronal precursor cells. Two mouse cell types were used: cerebellar neurons from post-natal day 3 mice (PND3) in which endogenous Dcx expression has already been reported  and mouse embryonic stem (ESR1) cells.
Cell specificity of pdcx 2kb transcriptional activity was observed in both heterogeneous cell cultures by transient expression of the eGFP protein upon transfection with pdcx 2kb-eGFP constructs (Figure 1b). In primary cerebellar cells, eGFP under the control of pdcx 2kb was detected only in cells expressing the endogenous Dcx gene and not in other cell types, such as GFAP-expressing astrocytes (Figure 1b: A-H). Control experiments using the widely active pCMV-eGFP construct revealed that eGFP fluorescence was detected indifferently in all cell types, neurons and glial cells alike. Both GFAP- and Dcx-positive cells were fluorescent (Figure 1b: I-P), showing that the transfection process was not cell-specific. Similarly, eGFP expression was only detected in ESR1 cells after neuronal differentiation and was limited to Dcx-positive or βIII-Tubulin-positive cells, confirming pdcx 2kb selectivity to Dcx-positive neuronal precursor cells in vitro (data not shown).
Ex vivo electroporation of embryonic mouse brains was also conducted to confirm cell selectivity of pdcx 2kb activity in a more physiological setting. pdcx 2kb-eGFP was transfected in brains of E14.5-E15.5 mice, a specific time point of corticogenesis . Dcx expression was observed in migrating cortical neurons originating from progenitor cells located near the ventricular proliferative zone. Following pdcx 2kb-eGFP transfection, fluorescence was observed around the electroporation site in the proliferative zone of the cerebral cortex. Fluorescent cells displayed morphology similar to that of migrating neuronal precursors (Figure 1c). Moreover, all fluorescent cells also expressed Dcx. Taken together, these qualitative analyses show that the 2kb-long fragment upstream of the Dcx gene possesses regulatory sequences sufficient to mimic the activity of the endogenous Dcx gene in mouse embryos and to limit its activity to Dcx-positive neuronal precursors.
Transcriptional activity of the Dcx promoter in differentiating ES cells
To study more efficiently the transcriptional regulation of the mouse Dcx gene, we chose to use mouse embryonic stem (ESR1) cells: these cells are able to proliferate indefinitely in vitro while retaining pluripotency, and also to differentiate into a large variety of cell types in vitro. Hence, mouse ES cells can differentiate into neural precursors able to generate functional neurons , astrocytes and oligodendrocytes [21, 22]. Using our protocol (see Material and Methods), induction of neuronal differentiation leads to a progressive change in ESR1 cell morphology to a characteristic cobblestone structure and, by neuronal differentiation day 8 (DD8), ESR1 cells begin to form long cellular processes. From DD8/10 on, bipolar cells proliferate and form rosettes.
Dcx protein was detected at DD6 of ESR1 differentiation (Figure 2) and was still present in immature neuronal cells-derived from ESR1 cells at DD8 and DD18. Based on these observations and on the detection of Dcx mRNA at DD4, we decided to use ESR1 at DD6 for further analysis of the transcriptional activity of the mouse Dcx promoter.
To characterize relevant regions of pdcx, we dissected the 2kb-long fragment into shorter fragments of 1.2 kb, 1 kb (obtained by PCR) and 249 bp (obtained by enzymatic restriction), and inserted them upstream of the luciferase reporter gene.
Comparison of the respective activities of all constructs (Figure 3a) in ESR1 cells at DD8 revealed a higher activity in cells transfected with pdcx 2kb than in control cells (figure 3b). Transcriptional activities were also higher in cells transfected with shorter fragments (pdcx 1kb and pdcx 249bp) than with pdcx 2kb (Figure 3b). In contrast, the 1.2kb-long pdcx fragment did not induce a transcriptional activity different from control, suggesting the presence of a transcriptional repressor region in this 200 bp fragment. In addition, deletion of 79 bp at the 3'end of pdcx 1kb (pdcx 1kb-) prevented the pdcx 1kb-induced increase of activity. This last result suggested the presence of important regulatory domains at the 3'end of pdcx, especially in a 79bp-long fragment. Similar effects on the transcriptional activities of the different constructs were observed in PND3 cerebellar cells (Figure 3c), confirming the presence of similar regulatory control mechanisms in neuronal precursors from both origins (ESR1 cells and primary cerebellar cells). However, a discrepancy is observed between the relative activity of pdcx 1kb and pdcx 249bp between both cell cultures (Figure 3b and 3c), maybe reflecting the fact that the target regulatory elements necessary for the Dcx gene expression are different in two cell types. Indeed, it is quite possible that activators or inhibitor elements, located in pdcx 1kb and pdcx 249bp respectively, are most needed during the differentiation of CGN compared to neuroblasts from ESC. At that stage (DD6), ESR1 cells are plated on gelatin-coated plates while cerebellar cells are plated on poly-ornithine substrate (necessary for cell adhesion) (see also below).
The same relative activities of the promoter fragments were maintained throughout the entire differentiation program in ESR1 cells (Figure 4). Indeed, when ESR1 cells were transfected every second day throughout the entire differentiation period and the luciferase activity measured 48 hours later, increasing levels of activities were observed along the process with a peak at the transfer onto poly-ornithine/lamin substrate for constructs pdcx 2kb, pdcx 1kb and pdcx 249bp. The time-course studies confirmed the inhibition or the significant reduction of the transcriptional activity of pdcx at all stages by deletion of 79b at the 3' end of the pdcx sequences in constructs pdcx 1kb and pdcx 249bp (pdcx 1kb- and pdcx 249bp-, respectively). Finally, we also examined the cellular specificity of pdcx 1kb and pdcx 249bp in differentiated ESR1 and PND3 cerebellar cells and confirmed that, similar to the pdcx 2kb construct (Figure 1b), both pdcx 1kb and pdcx 249bp fragments restricted the expression of the eGFP reporter gene in Dcx-expressing cells (data not shown).
Transcription factors regulating the mouse Dcx promoter
Comparative analyses were performed on the sequences of mouse, rat, human and chicken 2kb-long Dcx promoter fragments using the VISTA software (Figure 5). A high sequence similarity was found between mouse and rat pdcx 2kb sequences. Comparison between mouse and human sequences revealed that sequence conservation was not detected throughout the 2kb-long sequence, but was limited to a ± 500 bp portion located at the pdcx 2kb 3'-end. Similarly, sequence conservation between the mouse pdcx 2kb and the chicken pdcx 2kb was only observed in a 183bp-long fragment located at the 3'-end. In addition, the strongest sequence conservation between mouse, rat, human and chicken pdcx 2kb sequences was detected within this 183bp-long fragment (Figure 5). Further analysis, using the MatInspector software, revealed that many putative binding sites for members of several transcription factor families known to participate in neuronal differentiation/migration such as NEUROD, NEUROG, BRN, PAX, HOX, SOX and DLX are present in the 249bp-, 1kb-, 2kb-long Dcx promoter fragments (Additional file 1: Table S1). In particular, this analysis revealed four conserved consensus binding sites for known transcription factors in the 79b-long fragment located at the 3'end of the Dcx promoter (Figure 6): two perfect consensus sites for NF-Y/CAAT, one perfect site for LEF/TCF which are effectors of the canonical Wnt pathway and one imperfect site for HNF6/OC2 (75% conserved relative to consensus), members of the ONECUT family [23–25].
Expression of putative transcription factors during neuronal differentiation of mESC
To investigate which of these transcription factors, present in the 79 bp fragment and potentially involved in Dcx gene regulation, are expressed during neuronal differentiation of ESR1 cells, the levels of mRNA coding for Dcx and for each factor (Lef, Tcf1, Tcf3 and Tcf4, Hnf6 and Oc2, Nf-ya, Nf-yb and Nf-yc) were measured at different time-points during neuronal differentiation (Figure 7).
The abundance of each transcript at each stage was calculated relative to the Gapdh housekeeping gene mRNA, based on published results [26–28]. The observed pattern of Dcx transcript expression is consistent with that of Dcx protein synthesis during neuronal differentiation of ESR1 cells and with the observed transcriptional activity of the Dcx promoter (see above). No Dcx transcript was detected in undifferentiated ESR1 cells. Levels of Dcx transcripts progressively increased to reach a maximum at DD18 followed by a reduction at DD28. Each transcription factor transcript was detected in ESR1 cells. The temporal profile of Lef, Hnf6 and Tcf4 transcription factors presented patterns of expression similar to that of Dcx, suggesting that expression of these transcription factors is also dependent on neuronal differentiating time. Their levels were relatively low during the early phase of ESR1 cell differentiation (DD0-8), progressively increased during the late phase of the differentiation program to peak at DD18 when Dcx transcript levels were maximum. In contrast, Nf-ya, Nf-yb, Nf-yc and Oc2 transcripts displayed relatively constant steady state levels, with little variation during the entire differentiation program. The relative amounts of Tcf1 and Tcf3, seem to depend on the differentiation process, with Tcf3 decreasing during differentiation  and Tcf1 being apparently sensitive to the culture matrix substrate.
Since mRNA for each transcription factor was present in ESR1 cells and since no transcription factor could be discarded on the sole basis of the temporal expression profile of its transcript, selective mutagenesis experiments were undertaken.
To determine the relative importance of each DNA binding site present in the 79bp-long pdcx-luciferase fragment, we individually altered each putative binding site for LEF/TCF, HNF6/OC2 or NF-Y/CAAT in the Dcx promoter using site-directed mutagenesis to generate pdcx 249bp/Lef*, pdcx 249bp/Hnf6* and pdcx 249bp/Nf-y* (Figure 8). Then we compared the luciferase activities induced by each construct to that of pdcx 249bp by transient expression experiments in ESR1 cells at three stages of neuronal differentiation. At the beginning of the differentiation program (DD2), mutation of the NF-Y or HNF6 binding sites did not affect pdcx 249bp activity (Figure 8a). In contrast, mutation of the LEF/TCF site completely inhibited pdcx 249bp activity. Such inhibition was not detected in ESR1 cells at DD8 (Figure 8b). At that stage, the relative activity of every mutated pdcx 249b was below that of the wild type pdcx 249bp but higher than that of the 79bp-truncated pdcx 249bp. Finally, at DD20, when many ESR1 cells expressed the Dcx gene and displayed a neuronal phenotype, mutation of any of the four binding sites reduced the activity of pdcx 249bp to that of the 79bp-truncated pdcx 249bp (Figure 8c). Similar results were found using pdcx 1kb (data not shown) and in PND3 cerebellar cells (Figure 8d). Simultaneous mutation of all three binding sites was also performed (pdcx 249bp/Lef*/Hnf6*/Nf-y*). Transfection experiments revealed that the transcriptional activation of pdcx 249bp mutated for LEF, HNF6 and NF-Y binding sites is similar to the constructs with any one mutated site (Additional file 2: Figure S1) at all stages, suggesting that an additional, not yet identified factor is responsible for the observed residual activity at DD8. Altogether, these results demonstrate first of all the importance of LEF/TCF, HNF6/OC2 or NF-Y/CAAT DNA binding sites for Dcx promoter activity at various stages of neuronal differentiation and that the corresponding factors are part of the regulatory mechanisms controlling Dcx promoter activity. However, these transcription factors are not sufficient to induce full transcriptional activation of the Dcx gene. In addition, the results obtained with the LEF/TCF binding site reveal that this binding site could be more specifically involved in activating pdcx at early stages of neuronal differentiation of ESR1 cells.
This present study shows that 249bp-, 1kb-, 2kb-long DNA fragments located upstream of the Dcx coding sequence, are sufficient for in vitro specific Dcx expression: in heterogeneous differentiated neurons from mouse embryonic stem (ESR1) cells, in primary mouse cerebellar neurons (PND3) and in organotypic slice cultures. The regulatory activity of all three constructs, visualized by eGFP expression, overlapped endogenous expression of Dcx or βIII-Tubulin (data not shown) in immature neuronal cells. In addition, no eGFP expression was observed in non-neuronal cells. These results strongly suggest that the fragments isolated here are sufficient for specific neuronal expression in differentiating neural cells.
During our analysis of transcriptional activities of the deletion constructs, we observed a very weak activity of the 1.2 kb fragment relative to the 1 kb construct, suggesting that the 0.2 kb sequence upstream from pdcx 1kb could contain transcriptional repressor elements. To determine the regulatory element(s) susceptible to participate in transcriptional repression of Dcx expression, we analyzed this sequence with the MatInspector software http://www.genomatix.de, but no unique repressor element was identified. However, this 0.2 kb sequence holds a short tandem repeat (STR) of twenty-five CA repeats (Figure 6), that could act as positive or negative regulator of gene expression. Short tandem repeats have been identified and are widespread in coding and non-coding regions of eukaryotic genomes from yeast to humans [30, 31]. CA repeats are also potential Z-DNA-forming sequences that could affect gene expression. Indeed, STRs were shown to activate or repress gene expression depending on the length of the repeats [32, 33]. This potential repressive element was not further investigated in this work, but it certainly deserves further attention also in the context of Dcx-related disease.
Dcx is expressed in differentiating/migrating immature neurons of embryonic and adult CNS and PNS. Moreover, Dcx presents a maximum expression during corticogenesis (E14-E18 in mouse) and neurogenesis [18, 34]. Using a mouse ESC model of neuronal differentiation, we demonstrated that the transcriptional activity of the Dcx promoter increased during the differentiation program, with a maximum activity shortly after the cells were plated on poly-ornithine/laminin substrates . Both of these extracellular matrix (ECM) components were shown to promote the active extension of neuronal cell protrusions as well as their maturation [36–38]. In the present study, we further show that ECM components also promote expression of the endogenous Dcx protein, in a pattern fully consistent with the transcriptional activity of the identified promoter region during the same differentiation process. This interesting observation suggests that it is possible to reproduce the Dcx expression profile in an in vitro cell culture model and use it to better study the mechanisms involved in neuronal differentiation of ESC [1, 2, 5, 34, 39, 40].
DNA binding sites for several transcription factors (E2F, NeuroD1, Brn2,..), known to participate to neuronal and migration processes were pointed out by bioinformatics analyses of the 2kb-long DNA regulatory sequence of the mouse Dcx gene. Most of the transcription factor binding sites present on the mouse DNA regulatory sequence were also detected on a 3.5-kb DNA fragment upstream of the translation start codon of the human DCX gene . This human sequence included a sequence homologous to the sequence used in the present study and the first exon of the human DCX gene. Furthermore, deletion experiments revealed the presence of critical regulatory sequences in a short fragment showing high sequence homology across species. Within this sequence, three relevant consensus binding sites were detected. Each transcription factor selected in the pdcx 3'-end (Lef/Tcf, Hnf6/Oc2, Nf-y/CAAT) is known to play a role, in a time-dependent manner, in the neuronal differentiation program. Mutational analysis revealed the outstanding importance of the LEF/TCF potential binding site for activation in early stages of the differentiation process, while at later stages the activity seems to be evenly distributed among all the binding sites. Simultaneous mutation of all three binding sites located in the 79 bp did not abolish the transcriptional activity of the Dcx promoter, implying that Dcx residual expression could be caused by a not yet discovered transcription factor located in the 79 bp region. Interestingly, the three transcription factors whose expression pattern during neuronal differentiation correlated best with Dcx promoter activity were Hnf6, Tcf4 and Lef. The latter are mediators in the canonical Wnt pathway that participates in many developmental processes in vivo and in vitro[42–46]. The involvement of Lef in the first steps of Dcx gene activation is consistent with the observations that some effectors of the Wnt canonical pathway contribute to neuronal differentiation of pluripotent cells, at least at specific stages [45, 47]. Hirabayashi and co-workers proposed that the Wnt signaling pathway directs neuronal differentiation in the developing mouse neocortex . They showed that activated β-catenin induced differentiation of Neural Precursor Cells (NPCs) at specific stages, whereas other studies suggested that Wnt signaling promoted NPC self-renewal . LEF/TCF and the other identified transcription factor complexes also play a role at later stages of the neuronal differentiation of ESC.
In silico analysis of the Dcx promoter, combined with mutagenesis experiments and RT-PCR analyses singled out the interesting ONECUT factors. First, a putative binding element for HNF6/OC2 was identified (75% conserved relative to consensus) in the 79 bp sequence (four on the total sequence of pdcx 2kb); second, the Hnf6 mRNA expression profile matched that of Dcx and third, mutation of the HNF6 binding site abolished Dcx promoter activity. Together, these results suggest that ONECUT factors could be involved in Dcx regulation. Hnf6 and other ONECUT factors have been detected in mouse [23, 24], the zebrafish  and also in drosophila and ascidia developing nervous system [51, 52]. All this information suggests that HNF6 and other members of the ONECUT family could play a role during neuronal differentiation and possibly in Dcx regulation. Further experiments are currently underway in order to clarify ONECUT action on Dcx expression
Data presented in this study suggest that the maturation state of differentiating neuroblasts could be characterized by a specific transcriptional activity of the Dcx gene. Some data suggest that the mouse embryonic brain (E14) contains two distinct populations of Dcx-positive cells, according to their Dcx expression levels . In these Dcx-positive cells, isolated by flow cytometry from the brains of transgenic mice expressing pdcx-eGFP in embryonic, early postnatal and adult animals, cells with a low level of Dcx expression (Dcxlow) were multipotent as shown by their expression of nestin. On the other hand, Dcxhigh cells showed an established neuronal specification, characterized by their expression of neuronal markers like βIII-Tubulin or MAP2. These results support the idea that all Dcx+ neuronal precursors do not have the same potential to differentiate. In this study, neuronal cells obtained from differentiation of ESC or primary cell cultures from brain embryos form a heterogeneous neuronal cell population. In this context, it is not surprising that Dcx+ cells, obtained from ESC differentiation, display different levels of Dcx promoter activity. This most probably reflects an asynchrony of differentiating ESC stages in the same cell culture.
The present work provides a molecular and cellular study of regulatory sequences (pdcx 2kb, pdcx 1kb, pdcx 249bp), sufficient to promote specific neuronal expression of mouse Dcx in neuroblasts. We show here that Dcx expression is abolished when a specific region in the 3'-end of the promoter is lacking. In addition transcription factor binding sites (LEF/TCF, HNF6/OC2 and NF-Y/CAAT) localized in this promoter region seem to act in a time-dependent fashion on the transcriptional activity of the Dcx gene during neuronal differentiation of ESC. Future experiments on these short regulatory sequences will help to understand the transcriptional regulation of Dcx gene expression and, maybe to isolate precursors at defined stages of neuronal differentiation based on their Dcx expression.
All experimental procedures on animals were carried out according to the European Communities Council Directive (86/609/EEC) for care and use of Laboratory animals. The experimental protocols were reviewed and approved by the institutional Animal Care Committee.
ES cell culture medium ingredients (DMEM/F12, Neurobasal medium, B27 supplement, Bovine Serum Albumin and L-glutamine) were obtained from Invitrogen-Gibco (Merelbeke, Belgium); BMP4 (Bone Morphogenic Protein-4) was obtained from R&D Systems (Abingdon, United Kingdom); apo-transferrin, progesterone, insulin, putrescine, sodium selenite, laminin, poly-ornithine and all chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless specified otherwise and ESGRO® (LIF, Leukemia Inhibitory Factor) was from Chemicon International (Temicula, CA, USA) unless specified otherwise.
ESC Culture - Monoculture Differentiation and Transfection
ESR1 cells were maintained without feeder cells in serum-free culture medium. ESC were plated onto 0.1% gelatin-coated plates in N2B27 medium (as described by Ying et al., 2003 ) supplemented with ESGRO® (LIF) 103 Units and BMP4 10 ng/ml and incubated at 37°C in 5% CO2. The medium was renewed every day. Cells were plated every 3 days using a dissociation solution (trypsin 0.05%, chicken serum 1%, EDTA 0.53 mM). To start monolayer differentiation, corresponding to DD0, undifferentiated cells were dissociated and plated onto 0.1% gelatin-coated plates at 104cells/cm2 in N2B27 medium supplemented with ESGRO® (LIF) 103 Units. The medium (non-supplemented N2B27) was changed every other day during 8 days, until DD8. Then, at DD8, cells were dissociated and plated on poly-ornithine (100 μg/ml) and laminin (0.5 μg/ml)-coated plates. The medium was changed 2 h and 24 h after plating and every 2 days until 20 days of differentiation on porn/lam substrate, corresponding to DD28. ESR1 cells can differentiate into neural precursors, which could generate functional neurons , astrocytes, and oligodendrocytes [21, 22].
Transient transfection experiments were performed using FuGene-6 (Roche Applied Science, Roche, Mannheim, Germany) as described by the manufacturer. eGFP expression was checked 24 h, 48 h and 72 h after transfection or luciferase/β-galactosidase activity ratios were determined 48 hours after transfection. The luciferase activity was measured according to the Luciferase Assay System (from Promega, Leiden, The Netherlands) and is expressed in RLU (Relative Light Units). The β-galactosidase activity was determined by reacting 40 μl of lysate with 40 μl of β-galactosidase substrate containing ONPG (o-nitrophenyl-D-galactopyranoside) and the absorbance was measured at 420 nm.
Cerebellar Granule Neuron (CGN) Culture and Transfection
Primary cultures of CGNs were obtained from post-natal day 3 (PND3) 129/sv mice. Isolated cerebella were stripped off meninges in DPBS (Dulbecco's Phosphate-Buffered Saline) (Invitrogen-Gibco) supplemented with glucose (0.45%), minced, and treated with dissociation solution (0.25% trypsin, 0.01% DNase) for 25 min at 37°C. Cell dissociation was stopped by adding 0.5 ml of FBS (Fetal Bovine Serum) to the dissociation solution. Granule cells were then mechanically dissociated by two successive triturations and sedimentation steps in complete medium (DMEM, 25 mM KCl, 96 mM NaCl, 5 μM insulin, 2 mM glutamine, 1.5% glucose 30%, 1% sodium pyruvate, 5% heat-inactivated FBS, 10% horse serum), and resuspended in 3 ml of complete medium. Neurons were plated onto poly-ornithine (100 μg/ml)-coated 24-well culture plates (Nunc, Wiesbaden, Germany) at a density of ~1 × 104 cells/drop and incubated at 37°C in 5% CO2. The following day, transient transfection experiments were performed using FuGene-6 (Roche Applied Science) as described by the manufacturer. eGFP expression was checked 24 h, 48 h and 72 h after transfection and the cells were fixed for immunocytochemistry analysis or lysed for luciferase/β-galactosidase activity ratio determination 48 hours after transfection.
Immunocytochemistry (ICC) and Immunohistochemistry (IHC)
Glass coverslips were washed in nitric acid (65%) for 1-2 days, rinsed in water for 2-3 hours, then in ethanol 100% for 2 h, air-dried and sterilized by autoclaving. Cells were washed in TBS (Tris-Buffered Saline), fixed for 20 min in 4% PFA (paraformaldehyde) at 4°C, washed in TBS and permeabilized/blocked for minimum 1 h in blocking buffer (TBS, 1% BSA, 0.2% teleostean gelatin, 0.1% Triton-X100) at room temperature . For Immunohistochemistry, the blocking buffer was composed of TBS, 0.25% gelatin, 0.1% Triton-X100. The same buffer without Triton X100 was used for antibody incubations and washes. Cells were incubated overnight in primary antibody solution (Table 1) at 4°C (in humid chamber), washed 3 times and incubated for 1 h in secondary antibody solution at room temperature (in humid chamber). The latest wash was performed in TBS before mounting in Vectashield HardSet Mounting Medium with DAPI (Vector Laboratories, Peterborough, United Kingdom).
Western Blotting (WB)
After 2 washes with PBS, cells on 10 cm2 plates were lysed by adding 300 μl lysis buffer (0.15 M NaCl, 0.05 M TrisBase, 1% TritonX-100, 1% Sodium deoxycholate, 0.1% SDS) supplemented with protease inhibitor cocktail (Roche) and PMSF (phenylmethylsulfonyl fluoride). After centrifugation at 4°C, the supernatant was removed and the protein content was determined using Bradford reagent (Bio-Rad Laboratories, Hercules, CA, USA). Samples were boiled in sample buffer (2×: 4% SDS, 10% β-mercaptoethanol, 135 mM Tris-HCl pH6.8, 20% glycerol, 1% bromophenol blue). Proteins (20 μg/sample) were separated by 10% SDS-PAGE, and transferred onto PVDF (Amersham Hybond-P). Blots were blocked in TBST-BSA 1% and incubated overnight with the primary antibody at 4°C. The following day, membranes were washed and then incubated 1 h with the secondary antibody at room temperature before washes. Detection was performed using ECL Plus method (Amersham).
The Mus musculus Doublecortin cDNA sequence is available under GenBank Accession no. NM010025 and genomic DNA sequence available under GenBank Accession no. BX530055, (Sanger Institute, Cambridge United Kingdom).
Bacterial Colony PCR-based screening was performed on the Library clone RP23-377E2 Bacterial Artificial Chromosome (BAC) (Children's Hospital Oakland Research Institute, California), using the Elongase Enzyme Mix (Invitrogen-Gibco) and three different 5'-primers (pdcx forward F1, F1.2, F2) and one 3'-primer (pdcx reverse):
pdcx F 1: 5'-TTTGTCTCTCTCAGCCTCGG-3'
pdcx F 1.2: 5'-TTCTTAGGTGCTGCTTTCCC-3'
pdcx F 2: 5'-ACTGACCTCTGTTCAGTTCC-3'
pdcx R: 5'-GTTTTCTGCTGGTTGGGTG-3'
Each PCR product (1 kbp, 1.2 kbp, 2 kbp) was cloned into pGEM-T easy (Promega) and subjected to DNA sequencing with T7 and SP6 oligonucleotide primers (GIGA, University of Liège, Belgium). The derived sequence was confirmed by comparison with the mouse genomic DNA obtained from C57Bl/6J mice and available under NCBI nucleotide bank Accession no. BX530055. Different fragments were cut with Pst1, HindIII ( for pdcx 249bp) and Apa1 restriction enzymes (New England Biolabs, Ipswich, MA, USA) and cloned into the pEGFP1 vector (BD/Clontech, Heidelberg, Germany). Integrity of the putative Dcx gene regulatory sequences of Dcx gene, pdcx-(1 kbp, 1.2 kbp, 2 kbp)-eGFP was confirmed by sequencing (Génome Express, Meylan, France).
Total RNA was extracted from cells (at day 0, 4, 8 on gelatin and day 0, 10 and 20 on poly-ornithine/laminin of ESC differentiation program, corresponding to DD0, DD4, DD8, DD18 and DD28 respectively) using instapure solution (Roche Applied Science, Vilvoorde, Belgium). Total RNA (5 μg) was used for a reverse transcriptional reaction. PCR was then carried out in a final volume of 50 μl containing 2.5 U of Taq polymerase (Promega), 2 μl of each selected primer and 0.2 μl of Gapdh primers (10 μM each, from Eurogentec, Seraing, Belgium), 1 μl of dNTP mix (10 mM each, from Promega) and 1 μl of the RT product. The primers used are detailed in Table 2.
PCR products were analyzed on agarose gel (Eurogentec) and quantified using Image Master 1D Prime v3.01 program (Amersham). The results are shown as the relative amount of the mRNA of interest relative to the Gapdh housekeeping gene mRNA.
Site-directed mutagenesis of the LEF, HNF6 and NF-Y sites in the Dcx promoter was performed on pdcx 249bp-luc plasmid. Whole plasmids carrying the mutation were obtained by performing PCR using primers listed in Table 3. Amplification reactions were carried out in 50 μl total volume containing 2.5 U of Pfu polymerase (Promega), 2 μl of each primer (10 μM each; Eurogentec), 1 μl of dNTP mix (10 mM each; Promega) and 50 ng DNA template (pdcx 249bp-luc) and 2.5 units Pfu Ultra. The thermocycling program used was 94°C for 1 min, followed by 18 cycles of 94°C for 1 min, 55°C for 1 min, 72°C for 10 min and a final extension cycle of 72°C for 10 min. The template was degraded using 10 units of DpnI restriction endonuclease at 37°C for at least 2 h. After transformation of competent E. coli, recombinant plasmids were isolated and their sequence verified.
Ex vivo electroporation
Plasmids were prepared using the EndoFree Plasmid Kit (Qiagen, Hilden, Germany). E14.5 pregnant mice were anesthetized by gas and euthanized by cervical dislocation. The embryonic chain was removed from the mother, the embryos were isolated from the amniotic sac and decapitated. DNA was microinjected into lateral ventricles of isolated embryonic mouse heads placed in ice-cold L-15 medium supplemented with 3% glucose (1 M), 2.6% sodium bicarbonate (1 M) and 1% penicillin/streptomycin (100×). For DNA microinjection (using the FemtoJet apparatus, Eppendorf AG, Hamburg, Germany), 75-mm glass capillary tubes were pulled and tips were broken. Plasmid solutions were stained with Fast Green solution (0.05%) to monitor injection sites. Electroporations were performed on whole heads (skin and skull intact) using an ECM 830 electroporator (BTX) and the following parameters: five 50 ms long pulses separated by 1s long intervals at 50 V. After pulse delivery, the embryo heads were immersed in ice-cold L-15 supplemented with 3% glucose (1 M), 2.6% sodium bicarbonate (1 M) and 1% penicillin/streptomycin, brains were extracted and transferred into liquid 3% low melting agarose (37°C; Bio-Rad Laboratories, Hercules, CA, USA) and incubated on ice for 1 h. Embedded brains were cut coronally (250 μm) with a vibratome (VT1000S, Leica). Brain slices were transferred and maintained in organotypic slice cultures on sterilized culture plate inserts (0.4-μm pore size; Millicell-CM, Millipore Billerica, MA, USA). Brain slices were maintained in semi-dry conditions in wells containing Neurobasal medium supplemented with 2% B27, 1% N2, 1% penicillin/streptomycin. After 2 or 3 days, slices were fixed for 30 min in 4% PFA at 4°C and incubated overnight in sucrose solution (20%). The following day, slices were sectioned using a cryostat at 14 micron-thickness (LEICA CM3050S) and stained for immunofluorescence as previously described.
Statistical analyses were performed by one-way ANOVA followed by Dunnett's post hoc tests, using a GraphPad Prism program (GraphPad, San Diego, CA, USA). Each experiment was performed in triplicates and repeated on at least three different occasions. Individual comparisons are expressed as mean ± SD.
Cerebellar Granule Neurons
Day of Differentiation
Bone Morphogenic Protein-4
Glial fibrillary acidic protein
Leukemia Inhibitory Factor
mouse Embryonic Stem Cells
Post Natal Day
Lymphoid enhancer factor-1
Hepatocyte Nuclear Factor-6
Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, Vinet MC, Friocourt G, McDonnell N, Reiner O, Kahn A, et al.: Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron. 1999, 23 (2): 247-256. 10.1016/S0896-6273(00)80777-1.
des Portes V, Pinard JM, Billuart P, Vinet MC, Koulakoff A, Carrié A, Gelot A, Dupuis E, Motte J, Berwald-Netter Y, et al.: A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. Cell. 1998, 92 (1): 51-61. 10.1016/S0092-8674(00)80898-3.
Walker TL, Yasuda T, Adams DJ, Bartlett PF: The doublecortin-expressing population in the developing and adult brain contains multipotential precursors in addition to neuronal-lineage cells. Journal of Neuroscience. 2007, 27 (14): 3734-3742. 10.1523/JNEUROSCI.5060-06.2007.
Friocourt G, Koulakoff A, Chafey P, Boucher D, Fauchereau F, Chelly J, Francis F: Doublecortin functions at the extremities of growing neuronal processes. Cereb Cortex. 2003, 13 (6): 620-626. 10.1093/cercor/13.6.620.
Brown JP, Couillard-Després S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG: Transient expression of doublecortin during adult neurogenesis. J Comp Neurol. 2003, 467 (1): 1-10. 10.1002/cne.10874.
Mattar P, Britz O, Johannes C, Nieto M, Ma L, Rebeyka A, Klenin N, Polleux F, Guillemot F, Schuurmans C: A screen for downstream effectors of Neurogenin2 in the embryonic neocortex. Developmental Biology. 2004, 273 (2): 373-389. 10.1016/j.ydbio.2004.06.013.
Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J, Kuhn H, Aigner L: Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci. 2005, 21 (1): 1-14. 10.1111/j.1460-9568.2004.03813.x.
Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I, Cooper EC, Dobyns WB, Minnerath SR, Ross ME, et al.: Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell. 1998, 92 (1): 63-72. 10.1016/S0092-8674(00)80899-5.
Corbo JC, Deuel TA, Long JM, LaPorte P, Tsai E, Wynshaw-Boris A, Walsh C: Doublecortin is required in mice for lamination of the hippocampus but not the neocortex. Journal of Neuroscience. 2002, 22 (17): 7548-7557.
Ramos R: Heterotopia Formation in Rat but Not Mouse Neocortex after RNA Interference Knockdown of DCX. Cerebral Cortex. 2005, 16 (9): 1323-1331. 10.1093/cercor/bhj074.
Bai J, Ramos R, Ackman J, Thomas A, Lee R, Loturco J: RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat Neurosci. 2003, 6 (12): 1277-1283. 10.1038/nn1153.
Loturco J, Bai J: The multipolar stage and disruptions in neuronal migration. Trends in Neurosciences. 2006, 29 (7): 407-413. 10.1016/j.tins.2006.05.006.
Friocourt G, Liu JS, Antypa M, Rakic S, Walsh C, Parnavelas JG: Both doublecortin and doublecortin-like kinase play a role in cortical interneuron migration. Journal of Neuroscience. 2007, 27 (14): 3875-3883. 10.1523/JNEUROSCI.4530-06.2007.
Deuel TA, Liu JS, Corbo JC, Yoo SY, Rorke-Adams LB, Walsh C: Genetic interactions between doublecortin and doublecortin-like kinase in neuronal migration and axon outgrowth. Neuron. 2006, 49 (1): 41-53. 10.1016/j.neuron.2005.10.038.
Zhou Q, Anderson DJ: The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell. 2002, 109 (1): 61-73. 10.1016/S0092-8674(02)00677-3.
Paratore C, Hagedorn L, Floris J, Hari L, Kléber M, Suter U, Sommer L: Cell-intrinsic and cell-extrinsic cues regulating lineage decisions in multipotent neural crest-derived progenitor cells. Int J Dev Biol. 2002, 46 (1): 193-200.
Kintner C: Neurogenesis in embryos and in adult neural stem cells. J Neurosci. 2002, 22 (3): 639-643.
Gleeson JG, Lin PT, Flanagan LA, Walsh CA: Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron. 1999, 23 (2): 257-271. 10.1016/S0896-6273(00)80778-3.
Nadarajah B, Alifragis P, Wong RO, Parnavelas JG: Neuronal migration in the developing cerebral cortex: observations based on real-time imaging. Cereb Cortex. 2003, 13 (6): 607-611. 10.1093/cercor/13.6.607.
Bibel M, Richter J, Schrenk K, Tucker K, Staiger V, Korte M, Goetz M, Barde Y: Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci. 2004, 7 (9): 1003-1009. 10.1038/nn1301.
Zhang JQ, Yu XB, Ma BF, Yu WH, Zhang AX, Huang G, Mao FF, Zhang XM, Wang ZC, Li SN, et al.: Neural differentiation of embryonic stem cells induced by conditioned medium from neural stem cell. Neuroreport. 2006, 17 (10): 981-986. 10.1097/01.wnr.0000227977.60271.ca.
Billon N, Jolicoeur C, Tokumoto Y, Vennström B, Raff M: Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1). EMBO J. 2002, 21 (23): 6452-6460. 10.1093/emboj/cdf662.
Lemaigre F: [Structure, function and physiopathological implications of HNF-6, a prototype of a new family of gene expression regulators]. Bull Mem Acad R Med Belg. 1999, 154 (6 Pt 2): 295-301.
Landry C, Clotman F, Hioki T, Oda H, Picard JJ, Lemaigre FP, Rousseau GG: HNF-6 is expressed in endoderm derivatives and nervous system of the mouse embryo and participates to the cross-regulatory network of liver-enriched transcription factors. Developmental Biology. 1997, 192 (2): 247-257. 10.1006/dbio.1997.8757.
Jacquemin P, Lannoy VJ, Rousseau GG, Lemaigre FP: OC-2, a novel mammalian member of the ONECUT class of homeodomain transcription factors whose function in liver partially overlaps with that of hepatocyte nuclear factor-6. J Biol Chem. 1999, 274 (5): 2665-2671. 10.1074/jbc.274.5.2665.
Willems E, Mateizel I, Kemp C, Cauffman G, Sermon K, Leyns L: Selection of reference genes in mouse embryos and in differentiating human and mouse ES cells. Int J Dev Biol. 2006, 50 (7): 627-635. 10.1387/ijdb.052130ew.
Reyes JH, O'Shea KS, Wys NL, Velkey JM, Prieskorn DM, Wesolowski K, Miller JM, Altschuler RA: Glutamatergic neuronal differentiation of mouse embryonic stem cells after transient expression of neurogenin 1 and treatment with BDNF and GDNF: in vitro and in vivo studies. J Neurosci. 2008, 28 (48): 12622-12631. 10.1523/JNEUROSCI.0563-08.2008.
Abranches E, Silva M, Pradier L, Schulz H, Hummel O, Henrique D, Bekman E: Neural differentiation of embryonic stem cells in vitro: a road map to neurogenesis in the embryo. PLoS ONE. 2009, 4 (7): e6286-10.1371/journal.pone.0006286.
Pereira L, Yi F, Merrill BJ: Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. Mol Cell Biol. 2006, 26 (20): 7479-7491. 10.1128/MCB.00368-06.
Tóth G, Gáspári Z, Jurka J: Microsatellites in different eukaryotic genomes: survey and analysis. Genome Res. 2000, 10 (7): 967-981. 10.1101/gr.10.7.967.
Katti MV, Ranjekar PK, Gupta VS: Differential distribution of simple sequence repeats in eukaryotic genome sequences. Mol Biol Evol. 2001, 18 (7): 1161-1167.
Huang T-S, Lee C-C, Chang A-C, Lin S, Chao C-C, Jou Y-S, Chu Y-W, Wu C-W, Whang-Peng J: Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression. Biochem Biophys Res Commun. 2003, 300 (4): 901-907. 10.1016/S0006-291X(02)02962-5.
Gebhardt F, Zänker KS, Brandt B: Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem. 1999, 274 (19): 13176-13180. 10.1074/jbc.274.19.13176.
Meyer G, Perez-Garcia CG, Gleeson J: Selective expression of doublecortin and LIS1 in developing human cortex suggests unique modes of neuronal movement. Cereb Cortex. 2002, 12 (12): 1225-1236. 10.1093/cercor/12.12.1225.
Ying Q, Stavridis M, Griffiths D, Li M, Smith A: Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotech. 2003, 21 (2): 183-186. 10.1038/nbt780.
Flanagan LA, Rebaza LM, Derzic S, Schwartz PH, Monuki ES: Regulation of human neural precursor cells by laminin and integrins. J Neurosci Res. 2006, 83 (5): 845-856. 10.1002/jnr.20778.
De Arcangelis A, Georges-Labouesse E: Integrin and ECM functions: roles in vertebrate development. Trends Genet. 2000, 16 (9): 389-395. 10.1016/S0168-9525(00)02074-6.
Andressen C, Adrian S, Fässler R, Arnhold S, Addicks K: The contribution of beta1 integrins to neuronal migration and differentiation depends on extracellular matrix molecules. Eur J Cell Biol. 2005, 84 (12): 973-982. 10.1016/j.ejcb.2005.09.017.
Hannan AJ, Henke RC, Seeto GS, Capes-Davis A, Dunn J, Jeffrey PL: Expression of doublecortin correlates with neuronal migration and pattern formation in diverse regions of the developing chick brain. J Neurosci Res. 1999, 55 (5): 650-657. 10.1002/(SICI)1097-4547(19990301)55:5<650::AID-JNR12>3.0.CO;2-S.
Lee SH, Kim YJ, Lee KM, Ryu S, Yoon BW: Ischemic preconditioning enhances neurogenesis in the subventricular zone. Neuroscience. 2007, 146 (3): 1020-1031. 10.1016/j.neuroscience.2007.02.058.
Karl C, Couillard-Despres S, Prang P, Munding M, Kilb W, Brigadski T, Plotz S, Mages W, Luhmann H, Winkler J, et al.: Neuronal precursor-specific activity of a human doublecortin regulatory sequence. J Neurochem. 2005, 92 (2): 264-282. 10.1111/j.1471-4159.2004.02879.x.
Tang K, Yang J, Gao X, Wang C, Liu L, Kitani H, Atsumi T, Jing N: Wnt-1 promotes neuronal differentiation and inhibits gliogenesis in P19 cells. Biochemical and Biophysical Research Communications. 2002, 293 (1): 167-173. 10.1016/S0006-291X(02)00215-2.
Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaar G, Markman M, Lamers W, Destree O, Clevers H: Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol. 1998, 18 (3): 1248-1256.
Katoh M: Regulation of WNT signaling molecules by retinoic acid during neuronal differentiation in NT2 cells: threshold model of WNT action (review). Int J Mol Med. 2002, 10 (6): 683-687.
Haegele L, Ingold B, Naumann H, Tabatabai G, Ledermann B, Brandner S: Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Mol Cell Neurosci. 2003, 24 (3): 696-708. 10.1016/S1044-7431(03)00232-X.
Czyz J, Wobus A: Embryonic stem cell differentiation: the role of extracellular factors. Differentiation. 2001, 68 (4-5): 167-174. 10.1046/j.1432-0436.2001.680404.x.
Kielman MF, Rindapää M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R: Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet. 2002, 32 (4): 594-605. 10.1038/ng1045.
Hirabayashi Y: The Wnt/-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development. 2004, 131 (12): 2791-2801. 10.1242/dev.01165.
Viti J, Gulacsi A, Lillien L: Wnt regulation of progenitor maturation in the cortex depends on Shh or fibroblast growth factor 2. Journal of Neuroscience. 2003, 23 (13): 5919-5927.
Hong SK, Kim CH, Yoo KW, Kim HS, Kudoh T, Dawid IB, Huh TL: Isolation and expression of a novel neuron-specific onecut homeobox gene in zebrafish. Mech Dev. 2002, 112 (1-2): 199-202. 10.1016/S0925-4773(01)00647-5.
Sasakura Y, Makabe KW: A gene encoding a new ONECUT class homeodomain protein in the ascidian Halocynthia roretzi functions in the differentiation and specification of neural cells in ascidian embryogenesis. Mech Dev. 2001, 104 (1-2): 37-48. 10.1016/S0925-4773(01)00352-5.
Nguyen DN, Rohrbaugh M, Lai Z: The Drosophila homolog of Onecut homeodomain proteins is a neural-specific transcriptional activator with a potential role in regulating neural differentiation. Mech Dev. 2000, 97 (1-2): 57-72. 10.1016/S0925-4773(00)00431-7.
Bibel M, Richter J, Schrenk K, Tucker K, Staiger V, Korte M, Goetz M, Barde Y: Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci. 2004, 7 (9): 1003-1009. 10.1038/nn1301.
Matsuo N, Kawamoto S, Matsubara K, Okubo K: Cloning and developmental expression of the murine homolog of doublecortin. Biochemical and Biophysical Research Communications. 1998, 252 (3): 571-576. 10.1006/bbrc.1998.9698.
Howe D, Bromidge T: Variation of LEF-1 mRNA expression in low-grade B-cell non-Hodgkin's lymphoma. Leuk Res. 2006, 30 (1): 29-32. 10.1016/j.leukres.2005.06.004.
Murakami T, Toda S, Fujimoto M, Ohtsuki M, Byers HR, Etoh T, Nakagawa H: Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Biochemical and Biophysical Research Communications. 2001, 288 (1): 8-15. 10.1006/bbrc.2001.5719.
Pierreux CE, Vanhorenbeeck V, Jacquemin P, Lemaigre FP, Rousseau GG: The transcription factor hepatocyte nuclear factor-6/Onecut-1 controls the expression of its paralog Onecut-3 in developing mouse endoderm. J Biol Chem. 2004, 279 (49): 51298-51304. 10.1074/jbc.M409038200.
Jacquemin P, Pierreux CE, Fierens S, van Eyll JM, Lemaigre FP, Rousseau GG: Cloning and embryonic expression pattern of the mouse Onecut transcription factor OC-2. Gene Expr Patterns. 2003, 3 (5): 639-644. 10.1016/S1567-133X(03)00110-8.
Tomita T, Kimura S: Regulation of mouse Scgb3a1 gene expression by NF-Y and association of CpG methylation with its tissue-specific expression. BMC Mol Biol. 2008, 9: 5-10.1186/1471-2199-9-5.
Li B, Mackay DR, Dai Q, Li TW, Nair M, Fallahi M, Schonbaum CP, Fantes J, Mahowald AP, Waterman ML, et al.: The LEF1/beta -catenin complex activates movo1, a mouse homolog of Drosophila ovo required for epidermal appendage differentiation. Proc Natl Acad Sci USA. 2002, 99 (9): 6064-6069. 10.1073/pnas.092137099.
Desaint S, Hansmannel F, Clémencet MC, Le Jossic-Corcos C, Nicolas-Frances V, Latruffe N, Cherkaoui-Malki M: NFY interacts with the promoter region of two genes involved in the rat peroxisomal fatty acid beta-oxidation: the multifunctional protein type 1 and the 3-ketoacyl-CoA B thiolase. Lipids in health and disease. 2004, 3: 4-10.1186/1476-511X-3-4.
This work was supported by grants of the F.N.R.S. (JCP), the EEC (Marie Curie IRG) (JCP). M. Piens is a recipient of a F.R.I.A. PhD studentship. M. Muller is a "Chercheur Qualifié du FNRS". We thank L. de Nijs (GIGA-Neurosciences, Université de Liège) for technical help to perform ex vivo electroporation experiments. We also thank Dr B. Rogister (GIGA-Neurosciences, Université de Liège) for his advices and suggestions and Dr A. Nagy (Mount Sinai Hospital, Toronto, Canada) and Dr D. Pirottin (Animal Genomic Unit-GIGA-R, Université de Liège) for providing ESR1 cells.
MP carried out the study design, plasmid constructions, cell cultures, transfections, western blotting, Immunocytochemistry, ex-vivo electroporation, data analysis and drafted the manuscript. MM participated in the study design, sequence homologies and manuscript writing. MB performed the confocal immunofluorescence study and PCR experiments. GB performed the pdcx 1kb-eGFP and pdcx 1kb--eGFP constructions. JCP participated in the study design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 2:Simultaneous mutation of the LEF, HNF6 and NF-Y binding sites in Dcx promoter. ESR1 cells were transfected with the indicated constructs at day of differentiation 0 (DD0) and luciferase activity relative to β-galactosidase activity was determined 48 hours later. The different constructs were pdcx 249bp-Luc, 79bp-deleted pdcx 249bp-Luc construct (pdcx 249bp--Luc) and pdcx 249bp-Luc with mutated binding site (pdcx 249bp/Lef*, pdcx 249bp/Hnf6*, pdcx 249bp/Nf-y2*, pdcx 249bp/Nf-y3* and pdcx 249bp/Lef*/Hnf6*/Nf-y2*) and the promoterless control (CTL). The activity of each construct is expressed relative to that of the pdcx 249bp-Luc construct, set arbitrarily to 1. Each value represents the mean ± SD of one transfection experiment, performed in triplicate. Asterisks mean significantly different from pdcx 249bp values at P < 0.05 (*) or P < 0.01 (**). (TIFF 868 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.